Stay Up-to-date with “Forefront” - Mayo Clinic Cancer Center’s Signature Online Magazine
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to finding new ways to prevent, detect, and treat cancer as well as alleviate symptoms. Yet, for the general public, locating new and late breaking research information can be a daunting task. The Internet is full of resources, some helpful – some not so helpful – and some information that may or may not be trustworthy or that can even be out-of-date.
Fortunately, Mayo Clinic researchers are anxious to share their work with you! A few years ago, the Cancer Center at Mayo Clinic launched "Forefront” - a publication of the Mayo Clinic Cancer Center dedicated to Mayo’s cutting-edge cancer research and the researchers who are leading the charge and putting cancer research into practice.
Every issue of “Forefront” provides an array of research on different types of cancer and introduces you to the researchers leading the efforts. The most recent edition includes the following content:
- Director's message: Reducing the burden of cancer - Mayo Clinic researchers are advancing new ways to help reduce side effects of cancer treatment.
- Shorter duration chemo for low-risk stage III colon cancer - Reducing the length of adjuvant therapy with oxaliplatin is effective and reduces toxicity.
- Nonmelanoma skin cancers on the rise - An increase in basal cell carcinoma and squamous cell carcinoma renews the call for caution in tanning.
- Genetic test accurately detects early pancreatic cancer - Biomarkers can potentially change the paradigm of clinical practice in patients with pancreatic cysts.
- List of breast cancer genes clarified - The results will help identify members of families who are at increased risk of breast cancer.
- Researchers ID protein interaction behind metastasis - Their work shows that there's a direct interaction between focal adhesion kinase and myosin.
- New print edition of "Forefront" - Read about cancer detection, multiple myeloma, colon cancer, a glioblastoma vaccine and more.
- Meet the Investigator: Andrea E. Wahner Hendrickson, M.D. - Dr. Wahner Hendrickson discusses ovarian cancer treatment, translational research and clinical trials.
You can subscribe to “Forefront” at any time or read the latest edition or any of the archived editions.
I hope you find this information valuable. Feel free to share with your friends and family. Happy reading!